OCCI Funding: How Much Did They Raise & Key Investors

How Much Did OCCI Raise?
Funding & Key Investors

OCCI, a network of research centers focused on conducting phase II-IV clinical trials, has secured $150K in total capital, with its most recent financing event yielding $150K. This major strategic investment underscores the company's established position in facilitating pharmaceutical and biotechnology research across Psychiatry, Neurology, and General Medicine.

What is OCCI?

OCCI

Business Services

Research & Development

Healthcare Services

OCCI operates as a group of research centers dedicated to the conduct of phase II-IV clinical trials, specializing in Psychiatry, Neurology, and General Medicine. Despite being locally owned, the organization has garnered national recognition from pharmaceutical and biotechnology firms for its efficacy as a clinical trials site. OCCI actively engages potential participants through direct outreach and online assessments to qualify them for ongoing research studies.

How much funding has OCCI raised?

OCCI has raised a total of $150K across 1 funding round:

2020

Debt

$150K

Debt (2020): $150K with participation from PPP

What's next for OCCI?

The company's recent major strategic investment, within the context of large-scale late-stage funding, suggests OCCI is poised for significant expansion or the enhancement of its research infrastructure. This capital infusion is likely to bolster its capabilities in attracting more complex and larger-scale clinical trials, further solidifying its reputation and operational capacity within the competitive landscape of medical research and development.

See full OCCI company page

See More Financial Insights